Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,900 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CT45A1-mediated MLC2 (MYL9) phosphorylation promotes natural killer cell resistance and outer cell fate in a cell-in-cell structure, potentiating the progression of microsatellite instability-high colorectal cancer.
Teng HW, Huang HY, Lin CC, Twu YC, Yang WH, Lin WC, Lan HY, Lin YY, Hwang WL. Teng HW, et al. Among authors: lin cc, lin yy, lin wc. Mol Oncol. 2024 Sep 25. doi: 10.1002/1878-0261.13736. Online ahead of print. Mol Oncol. 2024. PMID: 39322998 Free article.
CIP2A is a predictor of poor prognosis in colon cancer.
Teng HW, Yang SH, Lin JK, Chen WS, Lin TC, Jiang JK, Yen CC, Li AF, Chen PC, Lan YT, Lin CC, Hsu YN, Wang HW, Chen KF. Teng HW, et al. Among authors: lin jk, lin cc, lin tc. J Gastrointest Surg. 2012 May;16(5):1037-47. doi: 10.1007/s11605-012-1828-3. Epub 2012 Feb 11. J Gastrointest Surg. 2012. PMID: 22328001
BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy.
Teng HW, Huang YC, Lin JK, Chen WS, Lin TC, Jiang JK, Yen CC, Li AF, Wang HW, Chang SC, Lan YT, Lin CC, Wang HS, Yang SH. Teng HW, et al. Among authors: lin jk, lin cc, lin tc. J Surg Oncol. 2012 Aug 1;106(2):123-9. doi: 10.1002/jso.23063. Epub 2012 Feb 13. J Surg Oncol. 2012. PMID: 22331825
Comparison of cetuximab to bevacizumab as the first-line bio-chemotherapy for patients with metastatic colorectal cancer: superior progression-free survival is restricted to patients with measurable tumors and objective tumor response--a retrospective study.
Yang YH, Lin JK, Chen WS, Lin TC, Yang SH, Jiang JK, Lan YT, Lin CC, Yen CC, Tzeng CH, Teng HW. Yang YH, et al. Among authors: lin jk, lin cc, lin tc. J Cancer Res Clin Oncol. 2014 Nov;140(11):1927-36. doi: 10.1007/s00432-014-1741-0. Epub 2014 Jun 17. J Cancer Res Clin Oncol. 2014. PMID: 24934725
6,900 results